OTCMCWBHF
Market cap18mUSD
Jan 10, Last price
0.12USD
1D
-9.20%
1Q
-9.06%
IPO
-99.11%
Name
Charlotte's Web Holdings Inc
Chart & Performance
P/E
—
P/S
0.29
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
9.98%
Rev. gr., 5y
-1.90%
Revenues
63m
-14.82%
Net income
-24m
L-59.88%
CFO
-15m
L+189.48%
Earnings
Mar 03, 2025
Profile
Charlotte's Web Holdings, Inc. engages in farming, manufacturing, marketing, and selling hemp-derived cannabidiol (CBD) wellness products. The company's products categories include hemp extract oil tinctures, such as liquid products; gummies comprising sleep, stress, immunity, and exercise recovery products; and capsules, CBD topical creams, and lotions, as well as products for pets under the Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp brands. Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene, cannabigerol, cannabinol, terpenes, flavonoids, and other beneficial hemp compounds. The company distributes its products through retail outlets and health care practitioners, as well as online through its website. It has a collaboration between its CW Labs science division and the University at Buffalo's Center for Integrated Global Biomedical Sciences to advance hemp cannabinoid science through a research program; and scientific collaboration with McLean Hospital. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. Charlotte's Web Holdings, Inc. was founded in 2013 and is headquartered in Denver, Colorado.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | 63,155 -14.82% | 74,139 -22.85% | ||||||
Cost of revenue | 97,505 | 128,087 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | (34,350) | (53,948) | ||||||
NOPBT Margin | ||||||||
Operating Taxes | 529 | 91 | ||||||
Tax Rate | ||||||||
NOPAT | (34,879) | (54,039) | ||||||
Net income | (23,796) -59.88% | (59,313) -56.93% | ||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | (64) | |||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | 2,252 | 2,306 | ||||||
Long-term debt | 76,090 | 75,537 | ||||||
Deferred revenue | ||||||||
Other long-term liabilities | 15,161 | 33,384 | ||||||
Net debt | 19,522 | 7,262 | ||||||
| Cash flow | ||||||||
Cash from operating activities | (15,386) | (5,315) | ||||||
CAPEX | (3,691) | (265) | ||||||
Cash from investing activities | (3,506) | 395 | ||||||
Cash from financing activities | (251) | 52,389 | ||||||
FCF | (27,350) | 2,370 | ||||||
| Balance | ||||||||
Cash | 47,820 | 66,963 | ||||||
Long term investments | 11,000 | 3,618 | ||||||
Excess cash | 55,662 | 66,874 | ||||||
Stockholders' equity | (271,722) | (247,926) | ||||||
Invested Capital | 402,876 | 416,447 | ||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | 152,940 | 146,632 | ||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | (19,190) | (44,980) | ||||||
EV/EBITDA | ||||||||
Interest | 8,573 | |||||||
Interest/NOPBT | ||||||||